{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:50:37Z","timestamp":1740124237824,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11255-019-02331-x","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T10:01:32Z","timestamp":1574157692000},"page":"455-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Holmium laser enucleation of the prostate in Jehovah\u2019s Witness patients"],"prefix":"10.1007","volume":"52","author":[{"given":"Ashraf","family":"Selim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1972-0230","authenticated-orcid":false,"given":"Charles U.","family":"Nottingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadya E.","family":"York","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey A.","family":"Dauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Borofsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Boris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Lingeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"issue":"3","key":"2331_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132(3):474\u2013479","journal-title":"J Urol"},{"issue":"5 Suppl","key":"2331_CR2","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.juro.2008.03.141","volume":"179","author":"JT Wei","year":"2008","unstructured":"Wei JT, Calhoun E, Jacobsen SJ (2008) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 179(5 Suppl):S75\u2013S80. https:\/\/doi.org\/10.1016\/j.juro.2008.03.141","journal-title":"J Urol"},{"key":"2331_CR3","unstructured":"How Many of Jehovah\u2019s Witnesses Are There Worldwide? JW.ORG. https:\/\/www.jw.org\/en\/jehovahs-witnesses\/faq\/how-many-jw-members\/. Accessed 14 Feb 2019"},{"key":"2331_CR4","unstructured":"Why Don\u2019t Jehovah\u2019s Witnesses Accept Blood Transfusions? JW.ORG. https:\/\/www.jw.org\/en\/jehovahs-witnesses\/faq\/jehovahs-witnesses-why-no-blood-transfusions\/. Accessed 14 Feb 2019"},{"issue":"5","key":"2331_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)\u2013incidence, management, and prevention. Eur Urol. 50(5):969\u2013979. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.042(discussion 980)","journal-title":"Eur Urol."},{"issue":"6","key":"2331_CR6","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/S0022-5347(17)37628-0","volume":"147","author":"HA Doll","year":"1992","unstructured":"Doll HA, Black NA, McPherson K, Flood AB, Williams GB, Smith JC (1992) Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol 147(6):1566\u20131573","journal-title":"J Urol"},{"issue":"2 Pt 2","key":"2331_CR7","first-page":"999","volume":"167","author":"WK Mebust","year":"1989","unstructured":"Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 167(2 Pt 2):999\u20131003 (discussion 1004)","journal-title":"J Urol"},{"issue":"5","key":"2331_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/end.1998.12.457","volume":"12","author":"PJ Gilling","year":"1998","unstructured":"Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR (1998) Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 12(5):457\u2013459. https:\/\/doi.org\/10.1089\/end.1998.12.457","journal-title":"J Endourol"},{"issue":"3","key":"2331_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1464-410X.2011.10359.x","volume":"109","author":"PJ Gilling","year":"2012","unstructured":"Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 109(3):408\u2013411. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10359.x","journal-title":"BJU Int"},{"issue":"7","key":"2331_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11255-014-0646-9","volume":"46","author":"N Sun","year":"2014","unstructured":"Sun N, Fu Y, Tian T et al (2014) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a randomized clinical trial. Int Urol Nephrol 46(7):1277\u20131282. https:\/\/doi.org\/10.1007\/s11255-014-0646-9","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"2331_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1089\/end.2012.0505","volume":"27","author":"L Yin","year":"2013","unstructured":"Yin L, Teng J, Huang C-J, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604\u2013611. https:\/\/doi.org\/10.1089\/end.2012.0505","journal-title":"J Endourol"},{"issue":"3","key":"2331_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.eururo.2006.04.002","volume":"50","author":"LC Wilson","year":"2006","unstructured":"Wilson LC, Gilling PJ, Williams A et al (2006) A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 50(3):569\u2013573. https:\/\/doi.org\/10.1016\/j.eururo.2006.04.002","journal-title":"Eur Urol"},{"issue":"1","key":"2331_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eururo.2007.08.036","volume":"53","author":"RM Kuntz","year":"2008","unstructured":"Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53(1):160\u2013166. https:\/\/doi.org\/10.1016\/j.eururo.2007.08.036","journal-title":"Eur Urol"},{"issue":"1","key":"2331_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-7819-1-6","volume":"1","author":"RL Kuo","year":"2003","unstructured":"Kuo RL, Paterson RF, Kim SC, Siqueira TM, Elhilali MM, Lingeman JE (2003) Holmium laser enucleation of the prostate (HoLEP): a technical update. World J Surg Oncol 1(1):6. https:\/\/doi.org\/10.1186\/1477-7819-1-6","journal-title":"World J Surg Oncol"},{"issue":"5","key":"2331_CR15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.eururo.2007.04.074","volume":"52","author":"EA Elzayat","year":"2007","unstructured":"Elzayat EA, Elhilali MM (2007) Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52(5):1465\u20131471. https:\/\/doi.org\/10.1016\/j.eururo.2007.04.074","journal-title":"Eur Urol"},{"issue":"5 Suppl","key":"2331_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.urology.2005.06.006","volume":"66","author":"EA Elzayat","year":"2005","unstructured":"Elzayat EA, Habib EI, Elhilali MM (2005) Holmium laser enucleation of the prostate: a size-independent new \u201cgold standard\u201d. Urology 66(5 Suppl):108\u2013113. https:\/\/doi.org\/10.1016\/j.urology.2005.06.006","journal-title":"Urology"},{"issue":"3","key":"2331_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.juro.2009.11.034","volume":"183","author":"AE Krambeck","year":"2010","unstructured":"Krambeck AE, Handa SE, Lingeman JE (2010) Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 183(3):1105\u20131109. https:\/\/doi.org\/10.1016\/j.juro.2009.11.034","journal-title":"J Urol"},{"issue":"2","key":"2331_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.urology.2013.09.035","volume":"83","author":"CR Mitchell","year":"2014","unstructured":"Mitchell CR, Mynderse LA, Lightner DJ, Husmann DA, Krambeck AE (2014) Efficacy of holmium laser enucleation of the prostate in patients with non-neurogenic impaired bladder contractility: results of a prospective trial. Urology 83(2):428\u2013432. https:\/\/doi.org\/10.1016\/j.urology.2013.09.035","journal-title":"Urology"},{"issue":"Suppl 2","key":"2331_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1464-410x.2006.06097.x","volume":"97","author":"JM Fitzpatrick","year":"2006","unstructured":"Fitzpatrick JM (2006) The natural history of benign prostatic hyperplasia. BJU Int 97(Suppl 2):3\u20136. https:\/\/doi.org\/10.1111\/j.1464-410x.2006.06097.x","journal-title":"BJU Int"},{"issue":"3","key":"2331_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.juro.2018.05.048","volume":"200","author":"HE Foster","year":"2018","unstructured":"Foster HE, Barry MJ, Dahm P et al (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol 200(3):612\u2013619. https:\/\/doi.org\/10.1016\/j.juro.2018.05.048","journal-title":"J Urol"},{"issue":"6","key":"2331_CR21","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.juro.2008.08.019","volume":"180","author":"MR Humphreys","year":"2008","unstructured":"Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE (2008) Holmium laser enucleation of the prostate\u2013outcomes independent of prostate size? J Urol 180(6):2431\u20132435. https:\/\/doi.org\/10.1016\/j.juro.2008.08.019(discussion 2435)","journal-title":"J Urol"},{"issue":"3","key":"2331_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ncpuro1044","volume":"5","author":"AR Rastinehad","year":"2008","unstructured":"Rastinehad AR, Ost MC, VanderBrink BA, Siegel DN, Kavoussi LR (2008) Persistent prostatic hematuria. Nat Clin Pract Urol 5(3):159\u2013165. https:\/\/doi.org\/10.1038\/ncpuro1044","journal-title":"Nat Clin Pract Urol"},{"issue":"9","key":"2331_CR23","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1464-410X.2005.05849.x","volume":"96","author":"JF Donohue","year":"2005","unstructured":"Donohue JF, Hayne D, Karnik U, Thomas DR, Foster MC (2005) Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks. BJU Int 96(9):1319\u20131322. https:\/\/doi.org\/10.1111\/j.1464-410X.2005.05849.x","journal-title":"BJU Int"},{"issue":"5","key":"2331_CR24","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/01.ju.0000028607.29093.56","volume":"168","author":"JF Donohue","year":"2002","unstructured":"Donohue JF, Sharma H, Abraham R, Natalwala S, Thomas DR, Foster MC (2002) Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finasteride for decreasing operative blood loss. J Urol 168(5):2024\u20132026. https:\/\/doi.org\/10.1097\/01.ju.0000028607.29093.56","journal-title":"J Urol"},{"key":"2331_CR25","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.6061\/clinics\/2018\/e264","volume":"73","author":"T-Y Yang","year":"2018","unstructured":"Yang T-Y, Chen M, Lin W-R et al (2018) Preoperative treatment with 5\u03b1-reductase inhibitors and the risk of hemorrhagic events in patients undergoing transurethral resection of the prostate\u2014a population-based cohort study. Clin Sao Paulo Braz 73:e264. https:\/\/doi.org\/10.6061\/clinics\/2018\/e264","journal-title":"Clin Sao Paulo Braz"},{"issue":"7","key":"2331_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1089\/end.2016.0070","volume":"30","author":"MM El Tayeb","year":"2016","unstructured":"El Tayeb MM, Jacob JM, Bhojani N, Bammerlin E, Lingeman JE (2016) Holmium laser enucleation of the prostate in patients requiring anticoagulation. J Endourol 30(7):805\u2013809. https:\/\/doi.org\/10.1089\/end.2016.0070","journal-title":"J Endourol"},{"issue":"1","key":"2331_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1308\/1478708051414","volume":"87","author":"MS Gohel","year":"2005","unstructured":"Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR (2005) How to approach major surgery where patients refuse blood transfusion (including Jehovah\u2019s Witnesses). Ann R Coll Surg Engl 87(1):3\u201314. https:\/\/doi.org\/10.1308\/1478708051414","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"2331_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/TA.0b013e318176cc66","volume":"65","author":"DB Hughes","year":"2008","unstructured":"Hughes DB, Ullery BW, Barie PS (2008) The contemporary approach to the care of Jehovah\u2019s witnesses. J Trauma 65(1):237\u2013247. https:\/\/doi.org\/10.1097\/TA.0b013e318176cc66","journal-title":"J Trauma"},{"issue":"6","key":"2331_CR29","first-page":"654","volume":"46","author":"Y Bai","year":"2016","unstructured":"Bai Y, Castillo BS, Tchakarov A et al (2016) Providing hemostatic and blood conservation options for Jehovah\u2019s Witness patients in a large medical system. Ann Clin Lab Sci 46(6):654\u2013661","journal-title":"Ann Clin Lab Sci"},{"issue":"12","key":"2331_CR30","first-page":"1337","volume":"36","author":"Y Azuno","year":"1995","unstructured":"Azuno Y, Kaku K (1995) Percutaneous nephrolithotripsy supported by recombinant factor VIII in a patient with hemophilia A, a Jehovah\u2019s Witness. Rinsho Ketsueki 36(12):1337\u20131341","journal-title":"Rinsho Ketsueki"},{"issue":"4","key":"2331_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/BF03017330","volume":"49","author":"DM Moskowitz","year":"2002","unstructured":"Moskowitz DM, Perelman SI, Cousineau KM et al (2002) Multidisciplinary management of a Jehovah\u2019s Witness patient for the removal of a renal cell carcinoma extending into the right atrium. Can J Anaesth 49(4):402\u2013408. https:\/\/doi.org\/10.1007\/BF03017330","journal-title":"Can J Anaesth"},{"issue":"2","key":"2331_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4111\/kju.2014.55.2.102","volume":"55","author":"BW Lee","year":"2014","unstructured":"Lee BW, Park MG, Cho DY, Park SS, Yeo JK (2014) Preoperative erythropoietin administration in patients with prostate cancer undergoing radical prostatectomy without transfusion. Korean J Urol 55(2):102\u2013105. https:\/\/doi.org\/10.4111\/kju.2014.55.2.102","journal-title":"Korean J Urol"},{"issue":"5","key":"2331_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1590\/S1677-55382004000500003","volume":"30","author":"AM Nieder","year":"2004","unstructured":"Nieder AM, Simon MA, Kim SS, Manoharan M, Soloway MS (2004) Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah\u2019s Witnesses. Int Braz J Urol 30(5):377\u2013379","journal-title":"Int Braz J Urol"},{"issue":"4 Pt 1","key":"2331_CR34","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/01.ju.0000027901.47718.fc","volume":"168","author":"RM Kuntz","year":"2002","unstructured":"Kuntz RM, Lehrich K (2002) Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: a randomized prospective trial of 120 patients. J Urol 168(4 Pt 1):1465\u20131469. https:\/\/doi.org\/10.1097\/01.ju.0000027901.47718.fc","journal-title":"J Urol"},{"issue":"9","key":"2331_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1089\/end.2017.0095","volume":"31","author":"MW Zhang","year":"2017","unstructured":"Zhang MW, El Tayeb MM, Borofsky MS et al (2017) Comparison of perioperative outcomes between holmium laser enucleation of the prostate and robot-assisted simple prostatectomy. J Endourol 31(9):847\u2013850. https:\/\/doi.org\/10.1089\/end.2017.0095","journal-title":"J Endourol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-019-02331-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T04:33:54Z","timestamp":1605674034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-019-02331-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1007\/s11255-019-02331-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The following disclosures are listed as follows. JE Lingeman is a consultant for Boston Scientific and Lumenis. CA Dauw is a consultant for Boston Scientific. MS Borofsky is a consultant for Boston Scientific and Auris Health. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional review board approval was approved at our institution (number 101000224).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was not obtained on patients given the retrospective nature of the study. The study was approved by the IRB at our institution (number 101000224).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}